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The complex series of cellular and molecular interactions that comprise T  cell 
activation  can  be initiated  by diverse agents  including  antigen,  lectins,  tumor 
promoters, and monoclonal antibodies such as OKT3 and OKT1 1 (1, 2). Each 
of these activation signals ultimately influence T  cell growth and differentiation 
either by altering  the properties or rates of synthesis of existing proteins or by 
initiating  the  synthesis  of new ones.  In  this  regard,  the  early phase  of T  cell 
activation  is characterized  by an increase of cellular RNA content, synthesis of 
new proteins, and the development of receptiveness to further activation signals. 
Included among this newly induced network of cellular proteins are the interleu- 
kin  2 (IL-2) receptor, transferrin  (Tf) receptor, and the lymphokines, IL-2 and 
3' interferon (IFN-3") (3-6). Through interactions with its cellular receptor, IL-2 
is capable of maintaining  the long-term growth of normal T  cells in vitro (7, 8). 
Tf receptor  expression  enables T  cells to  import  Tf,  the  predominant  serum 
iron-binding  glycoprotein. Tf-mediated  delivery of iron is absolutely required 
for eukaryotic cell growth.  Although a  role for IFN-3" in T  cell growth has not 
yet been elucidated, IFN-3" does promote the differentiation of cytotoxic T  cells 
and  natural  killer cells, in addition  to its antiviral  activity (9).  T  cell activation 
also results in early expression of the proto-oncogene c-myc (10). c-myc encodes a 
DNA-binding protein that may control the transcription  of some cellular genes 
(11). Thus far, little is known about how these genes that control T  cell growth 
and differentiation  relate  to each  other.  It has been demonstrated  (4)  that  an 
interaction of IL-2 with its receptor is required for the expression of Tf receptors. 
It also has been suggested that  IL-2 is involved in the regulation  of expression 
of its own receptor (12-14) and of IFN-3" (12,  15). 
As a further step towards understanding the regulation of the genes encoding 
c-myc,  IL-2, IFN-3",  and receptors for IL-2 and Tf, we have studied the kinetics 
of induction  of these  genes  during  T  lymphocyte  activation.  Using  nuclear 
transcription  assays, we present data demonstrating  that expression  of each of 
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these genes is regulated at the level of transcription, and, with the exception of 
the Tf receptor, each is induced independently of de novo protein synthesis. 
Material and Methods 
Preparation of Cells.  Peripheral blood lymphocytes (PBL) from normal donors were 
isolated  by Ficoll-Hypaque gradient  density centrifugation.  T  cells  were prepared  by 
rosetting  PBL  with  sheep  red  blood cells  as  previously described (16).  T  cells  were 
routinely cultured in RPMI  1640 medium supplemented with 10% fetal calf serum, and 
stimulated with phytohema~glutinin (PHA) (1 ~g/ml) and phorbol myristate acetate (PMA) 
(20 ng/ml). 
Immobilization  of cDNA Probes on Nitrocellulose  Filters.  Linearized cDNAs specific for 
IL-2, IL-2 receptor (17), IFN-7, Tf receptor, c-myc, HLA, and pBR322 were denatured 
by boiling for 10 min and incubation in  1 N  NaOH for 20 min at room temperature. 
cDNAs were then neutralized in a buffer containing 1 M NaCI, 0.3 M NaAc, 0.5 M Tris 
(pH  7.5),  1 M  HCI and  transferred to  nitrocellulose filters using a  vacuum-manifold 
apparatus (Schleicher & Schuell, Inc., Keene, NH).  1 t~g of cDNA was applied to each 
filter, followed by rinsing in 6× SSC (1× SSC is 0.15 M NaCI,  0.015 M sodium citrate, 
pH 7.2), air drying, and baking in vacuo at 80°C for 2 h. 
In Vitro  Transcription  With Isolated  Nuclei.  Nuclear "run oW' experiments were per- 
formed as previously described (18). Briefly, nuclei from induced and uninduced T  cells 
were isolated by cell lysis in a buffer containing 0.05%  Nonidet P-40 and subsequent 
centrifugation through 2 M sucrose gradients. For in vitro transcription, nascent RNA 
chains were allowed to elongate in the presence of [a32P]UTP. Labeled nuclear RNA was 
then purified by DNase treatment, proteinase K digestion, phenol extraction, and ethanol 
precipitation. The labeled nuclear RNA was  then hybridized to excess specific cDNA 
immobilized on nitrocellulose filters. After 2 d, filters were washed and autoradiographed. 
The radioactivity bound was determined by liquid scintillation counting. The transcrip- 
tional activity of a specific gene is expressed as parts per million (ppm). To determine 
specific ppm, background hybridization to pBR322 DNA was substracted from the actual 
radioactivity measured. This specific value was then divided by the total amount of input 
counts per minute of radioactive nuclear RNA and multiplied by 10  6. 
Results 
Using nuclear transcription assays, we determined the time course of expres- 
sion of various genes in PHA- and PMA-stimulated T  cells. The transcriptional 
kinetics of genes encoding HLA, c-myc, IL-2, and IFN-y are presented in Fig.  I, 
A and B. As shown,  HLA is constitutively transcribed, but a  modest increase in 
transcriptional  activity occurred after  PHA  and  PMA  activation.  In  contrast, 
c-myc is not transcribed in resting T  cells. However, after stimulation, this gene 
was rapidly induced with peak transcription at 6-9 h. Transcriptional activity of 
IFN-3~  and  IL-2  lagged  behind  c-myc,  peaking  at  9  and  94  h,  respectively. 
Although not returning to basal levels during this assay, transcription of each of 
these genes declined after peaking,  reflecting the generally transient nature of 
expression of the genes involved in early T  cell activation. 
Also  shown  (Fig.  1)  are  the  kinetics  of transcription  for these  genes  in  the 
presence of cycloheximide. At  2  ×  10 -5  M,  cycloheximide inhibited >98%  of 
protein  synthesis  as judged  by  [3H]leucine  incorporation,  yet  revealed  a  cell 
viability of >85% at 48 h. Cycloheximide was added 30 min before stimulation 
with PHA and PMA to ensure inhibition of protein synthesis at early time points. 
As shown, cycloheximide did not significantly alter the induction of c-myc, IL-2, 
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FIGURE  I.  Kinetic  analysis  of  gene  transcription  during  human  T  cell activation.  After 
stimulation  with  PHA  and  PMA,  nuclei  were  isolated at  indicated  times and  assayed  for 
transcriptional activity of genes encoding (,4) HLA 03), c-myc (A); (B) IL-2 (V), IFN-2t (O); and 
(C) IL-2 receptor (<>) and Tf receptor (O). Relative transcription of these genes is expressed 
in parts per million and determined as described in Material and Methods. Shown in broken 
lines and closed symbols are the respective transcriptional activities in the presence of 2 x  10 -s 
M  cycloheximide.  Essentially identical  results  were  obtained  in  two additional  experiments 
using either the same or a different normal lymphocyte donor. 
be confidently  measured after 48 h due to decreases  in cell viability and dimin- 
ished recovery of ~2p-labeled nuclear RNA. 
As  shown  in  Fig.  1 C,  neither  IL-2  receptor  nor  Tf  receptor  genes  are 
transcribed  in  uninduced  T  cells.  However,  after  stimulation  with  PHA  and 
PMA,  the  IL-2  receptor  gene expression  was rapidly  induced,  with peak  tran- 
scriptional activity from 6 to 24 h. Induction of transcription of the Tf receptor 
occurred  much  more  slowly,  with  initiation  between  15  and  24  h  and  peak 
expression at 48 h.  The addition of cycloheximide  did not alter  IL-2 receptor 
gene expression.  However,  Tf receptor gene transcription did not occur in the 
presence  of this agent.  Thus,  among the  genes  investigated,  only Tf receptor 
gene expression appears to be dependent upon de novo protein synthesis during 
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Discussion 
Using an in vitro nuclear transcription  assay, we have studied the kinetics of 
activation  of select  genes  involved  in  T  cell  growth  and  differentiation.  We 
demonstrate that c-myc, IL-2, IL-2 receptor,  IFN-% and Tf receptor genes are 
transcriptionally  silent in resting T  cells, or at least below the level of detection 
of our assay system. After T  cell activation with  PHA and PMA, each of these 
genes was induced, with different kinetics.  PHA- and PMA-mediated activation 
of c-myc, IL-2,  IL-2  receptor,  and  IFN-~  genes  occurred  in  the  presence  of 
cycloheximide, indicating that protein synthesis was not required for expression. 
In contrast, Tf receptor gene expression was blocked by cycloheximide. 
Analysis of the  time  courses of induction  indicates  that  the  genes encoding 
c-myc and  IL-2  receptor  precede the  transcription  of each  of the  other  genes 
studied. This finding is consistent with previous studies by Kelly et al. (10), who 
detected  c-myc mRNA  accumulation  in  murine  T  cells  as  early  as  1  h  after 
stimulation  with concanavalin  A. The c-myc gene product is a  nuclear protein, 
whose deregulated expression secondary to chromosomal transiocation has been 
associated with Burkitt's iymphomas (11,  19). This protein has been implicated 
in transcriptional  modulation and appears to be involved in the transit  of cells 
from the Go to G1 phase of the cell cycle. However, as shown in this study, c-myc 
protein  production  is  not  required  for  IL-2,  IL-2  receptor,  or  IFN-~/  gene 
expression, since the induction of these genes is independent of protein synthesis. 
IL-2 has been implicated in the regulation  of expression of its own receptor 
and  IFN-7 (12-15).  However, the results of the present study suggest that  the 
presence of IL-2 protein is not absolutely required for transcriptional  activation 
of either the c-myc, IL-2 receptor, or IFN-~ gene. First, c-myc, IL-2 receptor, and 
IFN-7  genes  are  transcribed  before  transcription  of the  IL-2  gene.  Second, 
inhibition  of protein synthesis with cycloheximide did not alter transcription  of 
these genes.  Reem and  Yeh (12) and  Welte et al.  (13) have demonstrated that 
recombinant  IL-2  can  up-regulate  IL-2  receptor  expression  in  suboptimally 
stimulated  T  cells. These studies involved activation of T  cells in the presence 
of dexamethasone or with submitogenic amounts of OKT3 monoclonal antibody. 
Similarly,  in  a  different  system,  we  have  observed  (14)  that  IL-2  alone  can 
augment  IL-2  receptor  gene  reexpression  in  activated  T  cells  that  have  lost 
>80% of their receptors during a  12 d  culture period.  In the present study we 
have activated T  cells with optimal concentrations of PHA and PMA. Thus, an 
amplifying  effect  of  IL-2  on  IL-2  receptor  gene  expression  may  have  been 
circumvented.  We conclude  that  IL-2  receptor and  IFN-~  gene  expression  is 
susceptible to  IL-2-mediated augmentation  in  suboptimally stimulated  T  cells. 
However, in fully stimulated T  cells, IL-2 receptor and IFN-7 gene transcription 
can clearly occur independent of IL-2. 
Fox et al.  (20)  have suggested  that  IL-2  receptor  expression  occurs before 
IL-2  gene  activation  during  the  maturation  of thymic  T  lymphocytes.  These 
findings mirror the kinetics of IL-2 receptor and IL-2 gene expression that occur 
during  T  cell  activation.  Thus,  the  sequence of IL-2  and  IL-2  receptor  gene 
expression  in  activated  T  lymphocytes  established  in  this  study  appears  to 
recapitulate events in early T  cell ontogeny. 
In  contrast  to  the  genes  discussed above,  Tf receptor  gene  transcription  is KRONKE ET  AL.  BRIEF  DEFINITIVE REPORT  1597 
initiated late in the course of T  cell activation and its expression required de 
novo protein synthesis. This is consistent with the studies of Neckers and Coss- 
man (4), who demonstrated that Tf receptor expression requires an interaction of 
IL-2 with its cellular receptor. In conclusion, we suggest that the genes encoding 
c-myc, IL-2, IL-2 receptor, and IFN-y are members of a family of genes that are 
rapidly, independently, and transiently induced during T  cell activation. Expres- 
sion of these gene products may subsequently activate other genes, i.e., the Tf 
receptor gene, which are required for later steps in T  cell growth and differen- 
tiation. 
Summary 
Nuclear transcription assays were performed with isolated nuclei from human 
peripheral blood T  lymphocytes stimulated with phytohemagglutinin and phor- 
bol  myristate acetate  to  determine  the  kinetics  of transcriptional  activity of 
various genes occurring in T  cell activation. Although silent in resting T  cells, 
the genes encoding c-myc and the interleukin 2  (IL-2) receptor were induced 
early,  preceding  ~  interferon  (IFN-~'),  IL-2,  and  transferrin  receptor  gene 
transcription. Transcriptional activity of these genes fell after their respective 
peaks, indicating that the expression of these genes is a transient event during T 
cell activation. With the exception of the transferrin receptor gene, the kinetics 
of induction of these genes were not altered by concentrations of cycloheximide 
that inhibited protein synthesis. These data indicate that the induction of genes 
encoding c-myc,  IL-2,  IL-2  receptor,  and  IFN-7  occur  independently of the 
sequential production of the proteins they encode. 
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